Clinical benefit from palbociclib, letrozole and goserelin combination therapy for sweat gland carcinoma with neuroendocrine differentiation (SCAND).
Sofia TzoumpaClaudia BejarBéatrice VilletteBaptiste LouveauLaurent ZelekAntoine MartinOphélie BriardDjamela BitoutFrédéric CauxMaxime BattistellaSamia MourahJulia SanchezPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)